Su YouRong S, Ali Muhammad S, Pukenas Bryan A, Favilla Christopher G, Zanaty Mario, Hasan David M, Kung David K
Department of Neurosurgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Department of Neurosurgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
World Neurosurg. 2020 Mar;135:e657-e663. doi: 10.1016/j.wneu.2019.12.097. Epub 2019 Dec 24.
Endovascular procedures such as intraarterial (IA) vasodilator injection and balloon angioplasty are used to treat medically refractory cerebral vasospasm. The effects of IA therapy may be short lived and thus require multiple treatments. Balloon angioplasty also has limitations including transient occlusion of the spastic blood vessel, possible endothelial injury, and limited access to proximal vessels. We aim to demonstrate a novel technique using a stent retriever for the management of medically refractory vasospasm, especially in distal vessels. Compared with balloon angioplasty, stent retrievers provide a passive, self-limiting expansion of blood vessels. Other benefits over balloon angioplasty include 1) ability to simultaneously inject IA vasodilators, 2) limited contact and damage to vessel wall, 3) nonocclusive expansion, and 4) technical ease.
Fourteen blood vessels from 6 patients with symptomatic vasospasm after subarachnoid hemorrhage were identified. We injected 5 mg of IA vasodilator medication into the vasospastic segments without radiographic improvement in vessel diameter and blood flow. The stent retriever was deployed for 2-5 minutes in each vasospastic segment.
Distal anterior and posterior circulation segments were easily accessible with the stent retriever system. It resulted in improved vessel diameter and blood flow with subsequent improvement in neurologic examination. All patients demonstrated radiographic resolution of vasospasm. No procedural-related complications were noted.
We demonstrate the safety and efficacy of a novel technique for the treatment of medically refractory cerebral vasospasm using stent retriever angioplasty in distal vessels. Stent angioplasty can be used as an additional tool in the management of subarachnoid hemorrhage-induced cerebral vasospasm.
血管内介入手术,如动脉内(IA)血管扩张剂注射和球囊血管成形术,用于治疗药物难治性脑血管痉挛。IA治疗的效果可能是短暂的,因此需要多次治疗。球囊血管成形术也有局限性,包括痉挛血管的短暂闭塞、可能的内皮损伤以及近端血管的进入受限。我们旨在展示一种使用支架取栓器治疗药物难治性血管痉挛的新技术,尤其是在远端血管。与球囊血管成形术相比,支架取栓器能使血管被动、自限性扩张。相对于球囊血管成形术的其他优点包括:1)能够同时注射IA血管扩张剂;2)与血管壁的接触和损伤有限;3)非闭塞性扩张;4)技术操作简便。
确定了6例蛛网膜下腔出血后出现症状性血管痉挛患者的14条血管。我们在血管痉挛段注射了5mg IA血管扩张剂药物,但血管直径和血流在影像学上没有改善。在每个血管痉挛段将支架取栓器展开2 - 5分钟。
使用支架取栓器系统可轻松进入远端前循环和后循环段。这导致血管直径和血流改善,随后神经学检查也得到改善。所有患者血管痉挛在影像学上均得到缓解。未发现与手术相关的并发症。
我们证明了在远端血管使用支架取栓器血管成形术治疗药物难治性脑血管痉挛的新技术的安全性和有效性。支架血管成形术可作为蛛网膜下腔出血所致脑血管痉挛治疗中的一种辅助工具。